pubmed-article:2571379 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:2571379 | lifeskim:mentions | umls-concept:C0025011 | lld:lifeskim |
pubmed-article:2571379 | lifeskim:mentions | umls-concept:C0037633 | lld:lifeskim |
pubmed-article:2571379 | lifeskim:mentions | umls-concept:C1521827 | lld:lifeskim |
pubmed-article:2571379 | lifeskim:mentions | umls-concept:C1561577 | lld:lifeskim |
pubmed-article:2571379 | lifeskim:mentions | umls-concept:C1514811 | lld:lifeskim |
pubmed-article:2571379 | lifeskim:mentions | umls-concept:C1706462 | lld:lifeskim |
pubmed-article:2571379 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:2571379 | pubmed:dateCreated | 1989-11-1 | lld:pubmed |
pubmed-article:2571379 | pubmed:abstractText | The work reported here sought to assess the protection afforded by two stabilizing solutions (sorbitol-gelatin and glutamic acid-lactose) in preserving the potency of freeze-dried Schwarz strain measles virus during storage with a view to the production of reference preparations and working lots of virus suspensions. Stabilized virus suspensions and control suspensions were stored at -70 degrees C or were freeze-dried and stored at -20 degrees C, and their potency was determined over a storage period of 21 months. It was found that the sorbitol-gelatin imparted more satisfactory stability (r = +0.18) to the freeze-dried virus suspensions than did the glutamic acid-lactose. The results also indicate that sorbitol-gelatin, used under the conditions of this study, is an effective stabilizer in the preparation of freeze-dried suspensions of Schwarz strain measles virus employed as reference preparation working lots. | lld:pubmed |
pubmed-article:2571379 | pubmed:language | eng | lld:pubmed |
pubmed-article:2571379 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2571379 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:2571379 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2571379 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2571379 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2571379 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2571379 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2571379 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2571379 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2571379 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2571379 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:2571379 | pubmed:issn | 0085-4638 | lld:pubmed |
pubmed-article:2571379 | pubmed:author | pubmed-author:AkimuraO KOK | lld:pubmed |
pubmed-article:2571379 | pubmed:author | pubmed-author:de RizzoEE | lld:pubmed |
pubmed-article:2571379 | pubmed:author | pubmed-author:GallinaN MNM | lld:pubmed |
pubmed-article:2571379 | pubmed:author | pubmed-author:FangF LFL | lld:pubmed |
pubmed-article:2571379 | pubmed:author | pubmed-author:MendesI FIF | lld:pubmed |
pubmed-article:2571379 | pubmed:author | pubmed-author:MiyakiCC | lld:pubmed |
pubmed-article:2571379 | pubmed:author | pubmed-author:PralM MMM | lld:pubmed |
pubmed-article:2571379 | pubmed:author | pubmed-author:TakataC SCS | lld:pubmed |
pubmed-article:2571379 | pubmed:author | pubmed-author:TenórioE CEC | lld:pubmed |
pubmed-article:2571379 | pubmed:author | pubmed-author:TuchiyaH NHN | lld:pubmed |
pubmed-article:2571379 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:2571379 | pubmed:volume | 23 | lld:pubmed |
pubmed-article:2571379 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:2571379 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:2571379 | pubmed:pagination | 299-305 | lld:pubmed |
pubmed-article:2571379 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:2571379 | pubmed:meshHeading | pubmed-meshheading:2571379-... | lld:pubmed |
pubmed-article:2571379 | pubmed:meshHeading | pubmed-meshheading:2571379-... | lld:pubmed |
pubmed-article:2571379 | pubmed:meshHeading | pubmed-meshheading:2571379-... | lld:pubmed |
pubmed-article:2571379 | pubmed:meshHeading | pubmed-meshheading:2571379-... | lld:pubmed |
pubmed-article:2571379 | pubmed:meshHeading | pubmed-meshheading:2571379-... | lld:pubmed |
pubmed-article:2571379 | pubmed:meshHeading | pubmed-meshheading:2571379-... | lld:pubmed |
pubmed-article:2571379 | pubmed:meshHeading | pubmed-meshheading:2571379-... | lld:pubmed |
pubmed-article:2571379 | pubmed:meshHeading | pubmed-meshheading:2571379-... | lld:pubmed |
pubmed-article:2571379 | pubmed:meshHeading | pubmed-meshheading:2571379-... | lld:pubmed |
pubmed-article:2571379 | pubmed:meshHeading | pubmed-meshheading:2571379-... | lld:pubmed |
pubmed-article:2571379 | pubmed:meshHeading | pubmed-meshheading:2571379-... | lld:pubmed |
pubmed-article:2571379 | pubmed:meshHeading | pubmed-meshheading:2571379-... | lld:pubmed |
pubmed-article:2571379 | pubmed:meshHeading | pubmed-meshheading:2571379-... | lld:pubmed |
pubmed-article:2571379 | pubmed:year | 1989 | lld:pubmed |
pubmed-article:2571379 | pubmed:articleTitle | Sorbitol-gelatin and glutamic acid-lactose solutions for stabilization of reference preparations of measles virus. | lld:pubmed |
pubmed-article:2571379 | pubmed:publicationType | Journal Article | lld:pubmed |